Top analyst has harsh words for SpaceX debut: ‘We recommend that investors avoid this IPO’

A contrarian critique argues SpaceX’s expected $1.75 trillion IPO valuation is far too rich, with $80 billion in proceeds and $62.6 billion, or 78%, already earmarked for debt repayment and other obligations. The article says 2025 margins are negative 7% on sales and negative 3% ROIC, ranking SpaceX last among peers, while projected success requires $1.1 trillion in revenue and $248 billion in net profit—levels viewed as highly unrealistic. Governance risks, including Elon Musk’s control, mandatory arbitration, and limited shareholder rights, add to the negative investment case.

Analysis

The market is underestimating the negative read-through to the AI infrastructure complex if this IPO narrative shifts from scarcity-premium to governance/financing scrutiny. A transaction that effectively pre-allocates most proceeds to debt reduction and related-party obligations is not just company-specific; it signals that capital intensity in frontier AI is being funded with increasingly weaker shareholder protection, which can compress multiples for high-spend AI names that already trade on long-duration cash flow assumptions. The nearest second-order winners are likely the incumbent hyperscalers with fortress balance sheets and self-funded capex, while the losers are any leveraged or pre-profit AI aspirants that need repeated capital raises.

The bigger issue is timing: the equity may price well and still be a poor medium-term security if the capital structure forces dilution within 12-24 months. If the operating model cannot internally fund the data-center buildout, every incremental dollar of growth becomes more expensive than the last, because higher interest burden and future equity issuance both leak into per-share returns. That creates a setup where the IPO can “work” on day one while being structurally negative for post-lockup performance and for the broader private-market AI funding ecosystem.

Consensus is likely missing that governance risk becomes economically relevant only after the euphoria fades. The market may initially tolerate control provisions and arbitration risk if order flow is strong, but those same features become valuation overhangs when growth decelerates or capex surprises hit. The article also implies competitive pressure from large platforms could cap terminal margins, making the DCF math far more punitive than headline TAM rhetoric suggests. In that regime, the most vulnerable stocks are the ones already priced as if they own the AI end-state, not the ones actually generating it.

Key Decisions for Investors

• Short AMZN / GOOGL / MSFT on any AI-IPO enthusiasm spike over the next 1-4 weeks; use a basket approach because these names are the cleanest public proxies for capital-allocation discipline and can underperform if the market starts discounting AI capex intensity. Risk: broad AI multiple expansion could overwhelm the thesis; target a 2:1 downside-to-upside profile.
• Underweight META and ORCL versus the hyperscaler basket for the next 1-3 months; both are more exposed to incremental scrutiny around AI monetization versus spend, and the market may re-rate names with less obvious self-funding flexibility. Use a relative-value pair: long MSFT, short ORCL on rallies.
• If the IPO comes at the expected richness, consider a tactical short in any post-lockup or post-debut squeeze via options, not cash equity. Structure as buy puts or put spreads 2-4 months out to capture the likely transition from scarcity bidding to financing reality; keep premium risk defined.
• Avoid chasing SATS/CMCSA-style connectivity exposure as a supposed indirect beneficiary; the article’s setup argues the real value accrues to capital providers and suppliers, not downstream telecom rivals. If you want a defensive pair, long NDAQ against any broad market weakness is cleaner than buying the IPO ecosystem itself.
• Watch for a follow-on equity or debt announcement within 6-12 months; that is the catalyst that would validate the dilution thesis and likely widen spreads across the private AI complex. If that happens, increase shorts in levered growth names and trim any long exposure to AI infrastructure beta.